BACKGROUND: The underlying causes of mental retardation remain unknown in about half the cases. Recent array-CGH studies demonstrated cryptic imbalances in about 25% of patients previously thought to be chromosomally normal. OBJECTIVE AND METHODS: Array-CGH with approximately 3500 large insert clones spaced at approximately 1 Mb intervals was used to investigate DNA copy number changes in 81 mentally impaired individuals. RESULTS: Imbalances never observed in control chromosomes were detected in 20 patients (25%): seven were de novo, nine were inherited, and four could not have their origin determined. Six other alterations detected by array were disregarded because they were shown by FISH either to hybridise to both homologues similarly in a presumptive deletion (one case) or to involve clones that hybridised to multiple sites (five cases). All de novo imbalances were assumed to be causally related to the abnormal phenotypes. Among the others, a causal relation between the rearrangements and an aberrant phenotype could be inferred in six cases, including two imbalances of the X chromosome, where the associated clinical features segregated as X linked recessive traits. CONCLUSIONS: In all, 13 of 81 patients (16%) were found to have chromosomal imbalances probably related to their clinical features. The clinical significance of the seven remaining imbalances remains unclear. The limited ability to differentiate between inherited copy number variations which cause abnormal phenotypes and rare variants unrelated to clinical alterations currently constitutes a limitation in the use of CGH-microarray for guiding genetic counselling.
BACKGROUND: The underlying causes of mental retardation remain unknown in about half the cases. Recent array-CGH studies demonstrated cryptic imbalances in about 25% of patients previously thought to be chromosomally normal. OBJECTIVE AND METHODS: Array-CGH with approximately 3500 large insert clones spaced at approximately 1 Mb intervals was used to investigate DNA copy number changes in 81 mentally impaired individuals. RESULTS: Imbalances never observed in control chromosomes were detected in 20 patients (25%): seven were de novo, nine were inherited, and four could not have their origin determined. Six other alterations detected by array were disregarded because they were shown by FISH either to hybridise to both homologues similarly in a presumptive deletion (one case) or to involve clones that hybridised to multiple sites (five cases). All de novo imbalances were assumed to be causally related to the abnormal phenotypes. Among the others, a causal relation between the rearrangements and an aberrant phenotype could be inferred in six cases, including two imbalances of the X chromosome, where the associated clinical features segregated as X linked recessive traits. CONCLUSIONS: In all, 13 of 81 patients (16%) were found to have chromosomal imbalances probably related to their clinical features. The clinical significance of the seven remaining imbalances remains unclear. The limited ability to differentiate between inherited copy number variations which cause abnormal phenotypes and rare variants unrelated to clinical alterations currently constitutes a limitation in the use of CGH-microarray for guiding genetic counselling.
Authors: Heike Fiegler; Philippa Carr; Eleanor J Douglas; Deborah C Burford; Sarah Hunt; Carol E Scott; James Smith; David Vetrie; Patricia Gorman; Ian P M Tomlinson; Nigel P Carter Journal: Genes Chromosomes Cancer Date: 2003-04 Impact factor: 5.006
Authors: Cédric Le Caignec; Philippe De Mas; Marie-Claire Vincent; Michelle Bocéno; Georges Bourrouillou; Jean-Marie Rival; Albert David Journal: Am J Med Genet A Date: 2005-01-15 Impact factor: 2.802
Authors: S Solinas-Toldo; S Lampel; S Stilgenbauer; J Nickolenko; A Benner; H Döhner; T Cremer; P Lichter Journal: Genes Chromosomes Cancer Date: 1997-12 Impact factor: 5.006
Authors: Twila M Yobb; Martin J Somerville; Lionel Willatt; Helen V Firth; Karen Harrison; Jennifer MacKenzie; Natasha Gallo; Bernice E Morrow; Lisa G Shaffer; Melanie Babcock; Judy Chernos; Francois Bernier; Kathy Sprysak; Jesse Christiansen; Shelagh Haase; Basil Elyas; Margaret Lilley; Steven Bamforth; Heather E McDermid Journal: Am J Hum Genet Date: 2005-03-30 Impact factor: 11.025
Authors: S J Knight; R Regan; A Nicod; S W Horsley; L Kearney; T Homfray; R M Winter; P Bolton; J Flint Journal: Lancet Date: 1999-11-13 Impact factor: 79.321
Authors: D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson Journal: Nat Genet Date: 1998-10 Impact factor: 38.330
Authors: Björn Menten; Karen Buysse; Farah Zahir; Jan Hellemans; Sara J Hamilton; Teresa Costa; Carrie Fagerstrom; George Anadiotis; Daniel Kingsbury; Barbara C McGillivray; Marco A Marra; Jan M Friedman; Frank Speleman; Geert Mortier Journal: J Med Genet Date: 2007-01-12 Impact factor: 6.318
Authors: Mu Yang; Elena J Mahrt; Freeman Lewis; Gillian Foley; Thomas Portmann; Ricardo E Dolmetsch; Christine V Portfors; Jacqueline N Crawley Journal: Autism Res Date: 2015-02-07 Impact factor: 5.216
Authors: Juliane Hoyer; Alexander Dreweke; Christian Becker; Ina Göhring; Christian T Thiel; Maarit M Peippo; Ralf Rauch; Michael Hofbeck; Udo Trautmann; Christiane Zweier; Martin Zenker; Ulrike Hüffmeier; Cornelia Kraus; Arif B Ekici; Franz Rüschendorf; Peter Nürnberg; André Reis; Anita Rauch Journal: J Med Genet Date: 2007-06-29 Impact factor: 6.318
Authors: Justine Coppinger; Donna McDonald-McGinn; Elaine Zackai; Kate Shane; Joan F Atkin; Alexander Asamoah; Robert Leland; David D Weaver; Susan Lansky-Shafer; Karen Schmidt; Heidi Feldman; William Cohen; Judy Phalin; Berkley Powell; Blake C Ballif; Aaron Theisen; Elizabeth Geiger; Chad Haldeman-Englert; Tamim H Shaikh; Sulagna Saitta; Bassem A Bejjani; Lisa G Shaffer Journal: Hum Mol Genet Date: 2009-02-03 Impact factor: 6.150
Authors: Marijke Bauters; Hilde Van Esch; Michael J Friez; Odile Boespflug-Tanguy; Martin Zenker; Angela M Vianna-Morgante; Carla Rosenberg; Jaakko Ignatius; Martine Raynaud; Karen Hollanders; Karen Govaerts; Kris Vandenreijt; Florence Niel; Pierre Blanc; Roger E Stevenson; Jean-Pierre Fryns; Peter Marynen; Charles E Schwartz; Guy Froyen Journal: Genome Res Date: 2008-04-02 Impact factor: 9.043